Completed
Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis
NCT01318902
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
- Locations
-
- Tufts Medical Center Boston, Massachusetts, United States
- Boston Medical Center Boston, Massachusetts, United States
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
- Mayo Clinic Rochester, Minnesota, United States